Report on how AI is redefining market landscape - The global effervescent tablet market size is estimated to grow by USD 4.80 billion from 2024-2028, according to Technavio. The market is estimated to ...

Ms. Fogarty has served at Tonix since 2016, most recently as Executive Vice President, Product DevelopmentTonix is Preparing for Potential Launch ...

Ms. Fogarty has served at Tonix since 2016, most recently as Executive Vice President, Product Development Tonix is Preparing for Potential Launch of TNX-102 SL for the management of fibromyalgia with ...

The UK-based consumer healthcare company will be modernizing its facility along Brook Road, where it conducts R&D for such ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.

Featured pricing is subject to change. While there may be more rigorously-tested vitamin and supplement products available today than ever before, selecting the best multivitamin for men is a ...

Millions of Americans take multivitamins daily to fill nutritional gaps and boost their overall health. This practice has become so common that the multivitamin industry generates over $56 billion ...

One way to care for yourself is to ensure your body gets the essential nutrients it needs. A daily multivitamin, in addition to a healthy diet, can help. You may also want to consider certain dietary ...

Both assets are poised to enter registrational studies under accelerated approval pathways, according to Jefferies. GSK to Stay Out of Obesity—but not GLP-1s At JPM25 on Monday, GSK Chief Scientific ...

Depemokimab data reveals 72% reduction in hospitalizations; projected sales hit £4 billion. GSK plc GSK expects strong momentum in the specialty business segment to continue with growth from ...

The company makes a wide range of products, including Panadol pain relief tablets and Centrum vitamins. GSK has also sold down its holdings of Haleon, completing its separation from the consumer ...

Following GSK’s deal-heavy end to 2024, Chief Scientific Officer Tony Wood, Ph.D., doesn’t expect the trend to let up in the new year, zeroing in on partnerships that can expand knowledge ...